Effective Management of Type 2 Diabetes with SEIZMET TRIO 0.2

SEIZMET TRIO 0.2 

Glimepiride (2mg), Metformin SR (500mg), Voglibose (0.2mg)

Introduction to SEIZMET TRIO 0.2

SEIZMET TRIO 0.2 is a combination medication used to manage type 2 diabetes mellitus. This powerful combination includes Glimepiride (2mg), Metformin Sustained Release (SR) (500mg), and Voglibose (0.2mg). Together, these three components work synergistically to help control blood sugar levels in patients who require a comprehensive approach to their diabetes management.

Components of SEIZMET TRIO 0.2

Glimepiride (2mg)

Glimepiride is a sulfonylurea class medication that stimulates the release of insulin from pancreatic beta cells. This helps in lowering blood sugar levels, particularly after meals.

Metformin SR (500mg)

Metformin is a biguanide that decreases hepatic glucose production and improves insulin sensitivity. The sustained release formulation ensures a prolonged therapeutic effect with minimal gastrointestinal side effects.

Voglibose (0.2mg)

Voglibose is an alpha-glucosidase inhibitor that delays the absorption of carbohydrates from the intestine, thereby preventing postprandial hyperglycemia.

How SEIZMET TRIO 0.2 Works

• Glimepiride: Increases insulin secretion from the pancreas.
• Metformin SR: Reduces glucose production in the liver and enhances insulin sensitivity.
• Voglibose: Slows down carbohydrate absorption in the intestine.

Benefits of SEIZMET TRIO 0.2

• Comprehensive Blood Sugar Control: Targets multiple pathways to effectively manage blood glucose levels.
• Reduced Risk of Complications: Helps in reducing the risk of diabetes-related complications such as neuropathy, retinopathy, and nephropathy.
• Convenience: Combines three medications into one pill, improving patient compliance.

Dosage and Administration

• Recommended Dose: One tablet taken orally before each main meal.
• Administration Tips: Swallow the tablet whole with water. Do not crush or chew.

Side Effects of SEIZMET TRIO 0.2

Common Side Effects

• Nausea
• Diarrhea
• Hypoglycemia
• Flatulence

Rare Side Effects

• Allergic reactions
• Lactic acidosis
• Severe hypoglycemia

Precautions

• Medical History: Inform your doctor about any history of kidney or liver disease, heart problems, or allergies.
• Medication Interactions: Avoid taking this medication with other drugs that can cause hypoglycemia or lactic acidosis.
• Lifestyle: Maintain a balanced diet and regular exercise regimen.

Monitoring and Follow-Up

• Blood Sugar Levels: Regularly monitor fasting and postprandial blood sugar levels.
• HbA1c Levels: Check HbA1c levels every three months to assess long-term glycemic control.
• Kidney and Liver Function: Periodically assess kidney and liver function to prevent complications.

Conclusion

SEIZMET TRIO 0.2, a combination of Glimepiride, Metformin SR, and Voglibose, offers a comprehensive solution for managing type 2 diabetes. Its multifaceted approach targets different aspects of glucose regulation, making it an effective and convenient option for patients. Regular monitoring and adherence to prescribed dosages are essential for optimal results.  Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

   BUY NOW